Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Exercise slows down cognitive decline in older adults

Exercise in older people is associated with a slower rate of decline in thinking skills that occurs with aging. People who reported light to no exercise experienced a decline equal to 10 more years of aging as compared to people who reported moderate to intense exercise, according to a population-based observational study published in the March 23, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.

24 Mar 2016

Retinal thickness points to disability worsening in MS patients

The thickness of the peripapillary retinal nerve fibre layer (pRNFL) may help to predict worsening disability in patients with multiple sclerosis (MS), optical coherence tomography (OCT) ...

24 Mar 2016

Researchers use DNA sequencing technology to identify gene variants that affect susceptibility to SLE

Demonstrating the potential of precision medicine, an international study based at UT Southwestern Medical Center used next-generation DNA sequencing technology to identify more than 1,000 gene variants that affect susceptibility to systemic lupus erythematosus (SLE).

21 Mar 2016

New scaffold technology could someday help treat Parkinson's disease, other brain-related conditions

Scientists at Rutgers and Stanford universities have created a new technology that could someday help treat Parkinson's disease and other devastating brain-related conditions that affect millions of people.

18 Mar 2016

Psoriasis patients experience widespread bone loss

Researchers from the Genes, Development and Disease Group, headed by Erwin Wagner at the Spanish National Cancer Research Centre have discovered that psoriasis patients experience a widespread bone loss as a result of the disease.

17 Mar 2016

Excess comorbidity flagged in MS patients

Patients with multiple sclerosis have more comorbidities than would be expected for their age, even at the time of diagnosis, say researchers.

10 Mar 2016

Merck reports record results for 2015

Merck, a leading science and technology company, reported record results for 2015, emerging stronger from the transformation process that started in 2007. Net sales and EBITDA pre exceptionals were higher than ever before in Merck’s history of nearly 350 years.

From Merck 10 Mar 2016

People newly diagnosed with multiple sclerosis share risk factors of other chronic illnesses

People newly diagnosed with multiple sclerosis may often have other chronic health conditions as well, according to a study published in the March 9, 2016 online issue of Neurology®, the medical journal of the American Academy of Neurology.

10 Mar 2016

Added benefit of multiple sclerosis drug fingolimod not proven, says IQWiG

Since its approval in 2011, the multiple sclerosis drug fingolimod (Gilenya) has already undergone three early benefit assessments, all of which were mainly based on the approval study TRANSFORMS. After a new modification of the therapeutic indication by the regulatory authorities, the Federal Joint Committee again commissioned the German Institute for Quality and Efficiency in Health Care to examine the added benefit of the drug in accordance with the Act on the Reform of the Market for Medicinal Products.

9 Mar 2016

Metabolic syndrome treatment benefits MS patients

Oral antidiabetic medications have beneficial anti-inflammatory effects in patients with multiple sclerosis and metabolic syndrome, providing support for a link between metabolism and autoimmunity, researchers report.

9 Mar 2016

Novel mechanism identified to protect the brain from many neurodegenerative conditions

Scientists at Case Western Reserve University School of Medicine have identified a novel mechanism that could be used to protect the brain from damage due to stroke and a variety of neurodegenerative conditions, including sporadic Creutzfeldt-Jakob disease, Alzheimer's disease, and Parkinson's disease.

8 Mar 2016

Vitamin D deficiency during pregnancy linked to MS risk

Children born to mothers deficient in vitamin D during early pregnancy have an increased risk of developing multiple sclerosis as adults, researchers report.

8 Mar 2016

Kessler Foundation's Silvana L. Costa awarded Switzer Research Fellowship for research on MS

Silvana L. Costa, PhD, of Kessler Foundation has been awarded a Switzer Research Fellowship by the National Institute on Disability, Independent Living and Rehabilitation Research. The $70,000 Merit Award funds her research on "Processing Speed Deficits in Multiple Sclerosis: Exploring the Complex Sensorial Cognitive Motor Interaction."

7 Mar 2016

Young adults with hostile attitudes may experience memory and thinking problems decades later

Young adults with hostile attitudes or those who don't cope well with stress may be at increased risk for experiencing memory and thinking problems decades later, according to a study published in the March 2, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Mar 2016

Drinking more coffee may reduce risk of multiple sclerosis

Drinking a lot of coffee every day--more than 900 ml (30 fluid ounces) or around six cups--is linked to a reduced risk of multiple sclerosis (MS), finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.

7 Mar 2016

Childhood emotional abuse linked to adult migraine risk

Children who are emotionally abused may be more likely to experience migraines as young adults, according to a preliminary study released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016. The link between migraine and abuse was stronger for emotional abuse than for physical or sexual abuse in the study.

3 Mar 2016

Research shows nighttime lights may affect sleeping habits

If your neighborhood is well-lit at night, you may not be sleeping well, according to a study released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.

2 Mar 2016

Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients

Ocrelizumab (OCR) is a humanized monoclonal antibody that selectively targets CD20+B cells. In a randomized, double-blind, placebo-controlled Phase III study (ORATORIO), OCR significantly reduced disease activity in patients with primary progressive multiple sclerosis (PPMS).

27 Feb 2016

New drug shows promise against Huntington's disease

A drug that would be the first to target the cause of Huntington's disease (HD) is effective and safe when tested in mice and monkeys, according to data released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.

27 Feb 2016

Study: Most Ebola survivors experience brain symptoms more than six months after initial infection

Most of the 82 Ebola survivors in a new study from the world's largest Ebola outbreak had brain symptoms more than six months after the initial infection. The preliminary results will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.

25 Feb 2016

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Exercise slows down cognitive decline in older adults

Retinal thickness points to disability worsening in MS patients

Researchers use DNA sequencing technology to identify gene variants that affect susceptibility to SLE

New scaffold technology could someday help treat Parkinson's disease, other brain-related conditions

Psoriasis patients experience widespread bone loss

Excess comorbidity flagged in MS patients

Merck reports record results for 2015

People newly diagnosed with multiple sclerosis share risk factors of other chronic illnesses

Added benefit of multiple sclerosis drug fingolimod not proven, says IQWiG

Metabolic syndrome treatment benefits MS patients

Novel mechanism identified to protect the brain from many neurodegenerative conditions

Vitamin D deficiency during pregnancy linked to MS risk

Kessler Foundation's Silvana L. Costa awarded Switzer Research Fellowship for research on MS

Young adults with hostile attitudes may experience memory and thinking problems decades later

Drinking more coffee may reduce risk of multiple sclerosis

Childhood emotional abuse linked to adult migraine risk

Research shows nighttime lights may affect sleeping habits

Phase III study: Ocrelizumab significantly reduces disease activity in PPMS patients

New drug shows promise against Huntington's disease

Study: Most Ebola survivors experience brain symptoms more than six months after initial infection

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Newsletters you may be interested in